Total Payments
$9,529
2024 Payments
$311.61
Companies
38
Transactions
592
Medicare Patients
6,380
Medicare Billing
$694,255
Payment Breakdown by Category
Food & Beverage$9,282 (97.4%)
Education$247.12 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,282 | 580 | 97.4% |
| Education | $247.12 | 12 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,749 | 149 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,568 | 85 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,361 | 76 | $0 (2022) |
| Grifols USA, LLC | $453.33 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $437.75 | 20 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $413.84 | 26 | $0 (2022) |
| United Therapeutics Corporation | $365.66 | 14 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $356.26 | 17 | $0 (2024) |
| Mylan Specialty L.P. | $296.37 | 15 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $224.07 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $311.61 | 14 | Regeneron Healthcare Solutions, Inc. ($117.15) |
| 2023 | $208.86 | 7 | Inogen, Inc. ($95.42) |
| 2022 | $2,218 | 118 | AstraZeneca Pharmaceuticals LP ($478.99) |
| 2021 | $1,977 | 123 | GlaxoSmithKline, LLC. ($374.10) |
| 2020 | $1,262 | 84 | Boehringer Ingelheim Pharmaceuticals, Inc. ($233.58) |
| 2019 | $1,310 | 99 | GlaxoSmithKline, LLC. ($252.29) |
| 2018 | $1,062 | 69 | GlaxoSmithKline, LLC. ($334.41) |
| 2017 | $1,180 | 78 | GlaxoSmithKline, LLC. ($277.05) |
All Payment Transactions
592 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Immunology | ||||||
| 06/10/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Pulmonology | ||||||
| 05/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: COVID-19 | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Respiratory | ||||||
| 04/08/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 10/23/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Respiratory | ||||||
| 07/05/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Respiratory | ||||||
| 06/05/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $29.49 | General |
| Category: HFCWO | ||||||
| 05/10/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $42.63 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 04/11/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $32.90 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 02/27/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $43.16 | General |
| Category: NEUROLOGY | ||||||
| 01/05/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $19.89 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 12/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: ANTIBIOTIC | ||||||
| 12/12/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2022 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,856 | 3,846 | $777,998 | $288,261 |
| 2022 | 12 | 1,789 | 1,969 | $509,888 | $147,323 |
| 2021 | 11 | 1,282 | 1,579 | $441,540 | $131,955 |
| 2020 | 14 | 1,453 | 1,712 | $459,480 | $126,716 |
Total Patients
6,380
Total Services
9,106
Medicare Billing
$694,255
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 299 | 1,709 | $254,641 | $109,461 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 399 | 621 | $183,821 | $62,219 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 181 | 181 | $83,260 | $23,927 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 260 | 325 | $65,325 | $22,503 | 34.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 173 | 419 | $41,900 | $17,003 | 40.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 138 | 143 | $38,610 | $15,109 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 134 | 134 | $40,334 | $12,068 | 29.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 73 | $19,710 | $10,249 | 52.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 67 | 102 | $22,440 | $9,829 | 43.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 23 | 26 | $7,696 | $2,595 | 33.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 36 | 36 | $7,344 | $2,448 | 33.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 11 | 11 | $1,738 | $294.25 | 16.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 25 | 25 | $4,150 | $237.75 | 5.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 25 | 25 | $4,325 | $204.00 | 4.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 16 | 16 | $2,704 | $113.44 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 347 | 461 | $136,917 | $44,729 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 261 | 261 | $120,060 | $34,047 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 273 | 309 | $62,109 | $21,127 | 34.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 237 | 238 | $40,222 | $10,556 | 26.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 240 | 241 | $40,006 | $9,994 | 25.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 244 | 245 | $42,385 | $7,353 | 17.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 32 | $24,288 | $5,665 | 23.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 72 | 73 | $13,400 | $5,274 | 39.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 17 | $9,673 | $2,747 | 28.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 32 | $9,376 | $2,672 | 28.5% |
About Dr. David Denholm, MD
Dr. David Denholm, MD is a Internal Medicine healthcare provider based in Venice, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699763870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Denholm, MD has received a total of $9,529 in payments from pharmaceutical and medical device companies, with $311.61 received in 2024. These payments were reported across 592 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,282).
As a Medicare-enrolled provider, Denholm has provided services to 6,380 Medicare beneficiaries, totaling 9,106 services with total Medicare billing of $694,255. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Venice, FL
- Active Since 10/11/2005
- Last Updated 04/20/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699763870
Products in Payments
- OFEV (Drug) $731.87
- TRELEGY ELLIPTA (Drug) $719.61
- NUCALA (Biological) $612.05
- FASENRA (Biological) $558.91
- DUPIXENT (Biological) $487.93
- STIOLTO RESPIMAT (Drug) $466.37
- Prolastin-C Liquid (Biological) $412.95
- OPSUMIT (Drug) $341.79
- SYMBICORT (Drug) $339.24
- GLASSIA (Biological) $297.20
- ORENITRAM (Drug) $285.37
- Adempas (Drug) $224.07
- FASENRA (Drug) $208.73
- XARELTO (Drug) $205.63
- ANORO (Drug) $193.90
- Yupelri (Drug) $175.32
- Wakix (Drug) $143.49
- FARXIGA (Drug) $136.99
- BREO (Drug) $123.32
- SPIRIVA RESPIMAT (Drug) $112.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Venice
Yousuf Dawoodjee, Md, MD
Internal Medicine — Payments: $25,737
Internal Medicine $25,737
Dr. Rachid Macwar, M.d, M.D
Internal Medicine — Payments: $25,486
Internal Medicine $25,486
Dr. Jeffrey Glover, Do, DO
Internal Medicine — Payments: $20,250
Internal Medicine $20,250
Dr. Sheeba Mesghali Morales, M.d, M.D
Internal Medicine — Payments: $20,028
Internal Medicine $20,028
Dr. Andrew Murray, D.o, D.O
Internal Medicine — Payments: $15,609
Internal Medicine $15,609
Dr. Caren Taylor, M.d, M.D
Internal Medicine — Payments: $9,598
Internal Medicine $9,598